Retractable Technologies Inc

retractable.com

What Do They Do?

Sells safety syringes and retractable needles to healthcare providers.

How Do They Make Money?

Customers pay for shipped products under approved credit terms after invoicing; international customers generally prepay. Licensing fees depend on licensees’ sales or use.

FY2025 revenue by product or service revenue

Segment	Share	How money arrives
Licensing fees Licensed	0.0% FY2022: 0.0%	Licensed
Syringes Sold outright	65% FY2022: 91%	Sold outright
Blood Collection Products Sold outright	3.6% FY2022: 3.1%	Sold outright
EasyPoint Needles Sold outright	31% FY2022: 4.9%	Sold outright
Other Products Sold outright	0.1% FY2022: 0.5%	Sold outright

Who Are Their Customers?

Healthcare providers use the products. The company distributes through general-line and specialty distributors in the U.S. and international distributors, and markets to healthcare customers and purchasing representatives through a national direct-marketing network.

Do Revenues Turn Into Profits?

No. It lost $12.6M in FY2025.

Operating income, FY2025

−55% of revenue

▲ 0% (Loss) vs FY2024 (−$21.1M, −64%)

Net income, FY2025

−33% of revenue

▲ +6% (Loss) vs FY2024 (−$11.9M, −36%)

How Are They Changing?

Since the FY2025 annual report

Latest quarter: Q2 FY2026, the three months to Jun 30, 2026

Revenue: ▼ −31%; vs $10.4M in Q2 FY2025
Net income: ▲ Now profitable; vs −$87.5K in Q2 FY2025

Syringes share of revenue vs 56.8% in Q2 FY2025

Shrinking. Revenue fell 80% in 4 years, from $188.4M in FY2021 to $38.3M in FY2025, about 33% a year.

Revenue over time

Licensing fees Syringes Blood Collection Products EasyPoint Needles Other Products

$200M$100M$0

FY2021 FY2022 FY2023 FY2024 FY2025

Who Do They Compete With?

Competes with BD and Embecta

Comments